Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Figures/Tables List
space
 arrow  Articles citing this article
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

POSITION PAPER

Call for Comments on a Proposal To Improve Reporting of Clinical Trials in the Biomedical Literature

right arrow Working Group on Recommendations for Reporting of Clinical Trials in the Biomedical Literature.

1 December 1994 | Volume 121 Issue 11 | Pages 894-895


Published guidelines for reporting clinical-research data range from the succinct paragraph on statistics in the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" [1] to articles of differing detail [2-7] and books written for the clinical researcher [8-10]. Despite such excellent resources in the biomedical literature, neither investigators reporting clinical trials nor journal editors selecting reports of trials for publication follow those guidelines consistently. For this reason, a working group of medical journal editors, biostatisticians, researchers, and editors from biomedical institutions met to consider how reporting of clinical-trials data might be made more consistent and complete. The group proposed that 1) editors of journals publishing reports of clinical trials are the persons best positioned to promote better reporting by investigators submitting papers to their journals, and 2) a readily accessible guide to the most basic methodologic elements required in reports of clinical trials could be helpful to journal editors and peer reviewers in evaluating reports of trials submitted for publication.

On this basis, the group drafted the following checklist Table 1 and a proposal for its use: If journal editors incorporate such a checklist in their "Instructions for Authors," it can serve as a framework for authors submitting reports of clinical trials. If journal editors ask their peer-review panels to use such a checklist in evaluating the selection of manuscripts for publication, it can foster more uniformly complete and consistent reporting of clinical trials. Such a checklist could also be helpful to clinical investigators as a quick reference tool in planning and writing reports of their work and as a training tool for clinical trainees.


View this table:
[in this window]
[in a new window]
 
Table 1. Checklist of Information for Inclusion in Reports of Clinical Trials

 

Adequate statistical reporting of data from clinical trials must follow detailed, comprehensive guidelines, and this checklist can serve as no more than a reminder. Nonetheless, authors of clinical trials who use this checklist to report data would provide clinicians with more consistently complete and reliable information on which to base treatment decisions. They would also provide clinical investigators with the information needed for an accurate interpretation of findings across several clinical trials and, in the future, for more reliable meta-analyses [11] of all trials on a topic.

With the generous cooperation of several professional medical, statistical, and scientific editors' societies, this checklist is being disseminated as widely as possible for consideration and comment by editors of medical journals, clinical investigators, biostatisticians, and others who would benefit from more uniform reporting of clinical-trials data. The working group would appreciate receiving your comments on this checklist, the potential value of its use by authors if it were published in the "Instructions for Authors" section of different journals, and its usefulness to journal editors and reviewers as a tool for peer review. Please send your suggestions and comments by 15 March 1995 to: Working Group, c/o Neurosurgery Editorial Office, 1360 Ninth Avenue, Suite 210, San Francisco, CA 94122. If you wish to receive a copy of the final checklist, please send a stamped, self-addressed envelope or $1.00 U.S. equivalent for postage to this address, and it will be mailed to you as soon as possible.


Appendix
space

Members of the Working Group on Recommendations for Reporting of Clinical Trials in the Biomedical Literature, which met at the Asilomar Conference Grounds, Pacific Grove, California, 14 to 16 March 1994. Journal Editors: Martin L. Fackler, MD, Wound Ballistics Review (Hawthorne, Florida); Edward J. Huth, MD, Annals of Internal Medicine and The On-Line Journal of Clinical Trials (Philadelphia, Pennsylvania); Roy M. Pitkin, MD, Obstetrics and Gynecology (Los Angeles, California); Drummond Rennie, MD, Journal of the American Medical Association and University of California, San Francisco (San Francisco, California); Statisticians: Colin Begg, PhD, Memorial Sloan Kettering Cancer Center (New York, New York); Sander Greenland, DrPH, University of California, Los Angeles (Los Angeles, California); Ingram Olkin, PhD, Stanford University (Stanford, California); Donna F. Stroup, PhD, MSc, Centers for Disease Control and Prevention (Atlanta, Georgia); Biomedical Investigators: Dennis F. Deen, PhD, Brain Tumor Research Center (University of California, San Francisco, California); Joseph Lau, MD, New England Medical Center (Boston, Massachusetts); Biomedical Editors: Pamela Derish, MA, University of California, San Francisco (San Francisco, California); Susan Eastwood, ELS(D), University of California, San Francisco (San Francisco, California); Thomas Lang, MA, The Cleveland Clinic Foundation (Cleveland, Ohio); Information Scientist: Kirstin Nichols, MA, ALZA Corporation (Palo Alto, California). The working group appreciates support provided by the Asilomar Western Regional Conference and Northern California Chapter of the American Medical Writers Association.


Author and Article Information
space
up arrowTop
dotAuthor & Article Info
down arrowReferences

For members of the Working Group, see the Appendix.
Requests for Reprints: Susan Eastwood, ELS(D), Department of Neurological Surgery, Box 0926, c/o The Editorial Office, 1360 Ninth Avenue, Suite 210, San Francisco, CA 94122.


References
space
up arrowTop
up arrowAuthor & Article Info
dotReferences

1. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. JAMA. 1993; 269:2282-6.

2. Altman DG, Bland JM. Improving doctors' understanding of statistics. J R Statist Soc A. 1991; 54(Pt 2):223-67.

3. Altman DG, Gore SM, Gardner MJ, Popcock SJ. Statistical guidelines for contributors to medical journals. Br Med J. 1983; 286:1489-93.

4. Bailar JC 3d, Mosteller F. Guidelines for statistical reporting in articles for medical journals. Amplifications and explanations. Ann Intern Med. 1988; 108:266-73.

5. Chalmers TC, Smith H Jr, Blackburn B, Silverman B, Schroeder B, Reitman D, et al. A method for assessing the quality of a randomized control trial. Controlled Clin Trials. 1981; 2:31-49.

6. Finney DJ, Clarke BC. Guest editorial: code for presentation of statistical analyses. Phil Trans R Soc Lond B. 1992; 337:381-2 (code first appeared in Proc R Soc Lond B. 1992; 249:1-2).

7. Murray GD. The task of a statistical referee. Br J Surg. 1988; 75:664-7.

8. Bailar JC 3d, Mosteller F, eds. Medical Uses of Statistics. 2nd ed. Waltham, Massachusetts: NEJM Books; 1992:449.

9. Glantz SA. Primer of Biostatistics. 3rd ed. New York: McGraw-Hill; 1992; 440.

10. Dawson-Saunders B, Trapp RG. Basic and Clinical Biostatistics. 2nd ed. Norwalk, Connecticut: Appleton & Lange; 1994:344.

11. Olkin I. Reconcilable differences: gleaning insight from conflicting scientific studies. The Sciences. 1992; (Jul/Aug):30-6.


This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
D. Coultas
Ethical Considerations in the Interpretation and Communication of Clinical Trial Results
Proceedings of the ATS, May 1, 2007; 4(2): 194 - 199.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. K. Krzyzanowska, M. Pintilie, C. Brezden-Masley, R. Dent, and I. F. Tannock
Quality of Abstracts Describing Randomized Trials in the Proceedings of American Society of Clinical Oncology Meetings: Guidelines for Improved Reporting
J. Clin. Oncol., May 15, 2004; 22(10): 1993 - 1999.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. F. M. Strippoli, J. C. Craig, and F. P. Schena
The Number, Quality, and Coverage of Randomized Controlled Trials in Nephrology
J. Am. Soc. Nephrol., February 1, 2004; 15(2): 411 - 419.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
E. J. Huth and K. Case
Annals of Internal Medicine at Age 75: Reflections on the Past 25 Years
Ann Intern Med, July 2, 2002; 137(1): 34 - 45.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
D. E. Bruns
Laboratory-related Outcomes in Healthcare
Clin. Chem., August 1, 2001; 47(8): 1547 - 1552.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
D. Rennie
CONSORT Revised--Improving the Reporting of Randomized Trials
JAMA, April 18, 2001; 285(15): 2006 - 2007.
[Full Text] [PDF]


Home page
StrokeHome page
F. J. Bath, V. E. Owen, and P. M. W. Bath
Quality of Full and Final Publications Reporting Acute Stroke Trials : A Systematic Review
Stroke, October 1, 1998; 29(10): 2203 - 2210.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
C. L. Meinert
Beyond CONSORT: Need for Improved Reporting Standards for Clinical Trials
JAMA, May 13, 1998; 279(18): 1487 - 1489.
[Full Text] [PDF]


Home page
JAMAHome page
E. A. Balas, R. A. C. Kretschmer, W. Gnann, D. A. West, S. A. Boren, R. M. Centor, M. Nerlich, M. Gupta, T. D. West, and N. S. Soderstrom
Interpreting Cost Analyses of Clinical Interventions
JAMA, January 7, 1998; 279(1): 54 - 57.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
T W Meade, N. Wald, R. Collins, H. J Bromhead, N. W Goodman, L. B O'Toole, D. G Altman, D. Moher, and D. Rennie
CONSORT statement on the reporting standards of clinical trials
BMJ, April 12, 1997; 314(7087): 1126 - 1126.
[Full Text]


Home page
BMJHome page
D. G Altman
Better reporting of randomised controlled trials: the CONSORT statement
BMJ, September 7, 1996; 313(7057): 570 - 571.
[Full Text]


Home page
BMJHome page
T. Greenhalgh
Commentary: Scientific heads are not turned by rhetoric
BMJ, April 15, 1995; 310(6985): 987 - 988.
[Full Text]


box Article
 arrow  Table of Contents                
space
 arrow  Figures/Tables List
space
 arrow  Articles citing this article
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online